Compass Therapeutics, Inc. · NASDAQ:CMPX
Montanova Capital, LLC reported a 5.20% stake in Compass Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 13, 2025
Montanova Capital, LLC reported a 5.20% stake in Compass Therapeutics, Inc., 7,149,493 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 7,149,493
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Suvretta Capital Management, LLC | 5.20% | 7,149,493 |
| Averill Master Fund, Ltd. | 4.50% | 6,251,950 |
| Aaron Cowen | 5.20% | 7,149,493 |
Source
Related
- Compass Therapeutics, Inc.
- Montanova Capital, LLC
- Compass Therapeutics, Inc. shareholders
- Schedule 13G/A · Montanova Capital, LLC · Aug 21, 2025
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · May 15, 2026